Sildenafil, sold under the brand name Viagra among others, is a medication used to treat erectile dysfunction and pulmonary arterial hypertension.[7] It is also sometimes used off-label for the treatment of certain symptoms in secondary Raynaud's phenomenon. It is unclear if it is effective for treating sexual dysfunction in females.[7] It can be taken orally (swallowed by mouth), intravenously (injection into a vein), or through the sublingual route (dissolved under the tongue).[7] Onset when taken orally is typically within twenty minutes and lasts for about two hours.[7]
Common side effects include headaches, heartburn, and flushed skin.[7] Caution is advised in those with cardiovascular disease.[7] Rare but serious side effects include vision problems, hearing loss, and prolonged erection (priapism) that can lead to damage to the penis.[7] Sildenafil should not be taken by people on nitric oxide donors such as nitroglycerin, as this may result in a serious drop in blood pressure.[7]
Sildenafil acts by blocking phosphodiesterase 5 (PDE5), an enzyme that promotes breakdown of cGMP, which regulates blood flow in the penis.[7] It requires sexual arousal to work, and does not by itself cause or increase sexual arousal.[7] It also results in dilation of the blood vessels in the lungs.[7]
Pfizer originally discovered the medication in 1989 while looking for a treatment for angina.[8] It was approved for medical use in the United States and in the European Union in 1998.[4][7][8][9] In 2023, it was the 151st most commonly prescribed medication in the United States, with more than 3million prescriptions.[10][11] It is available as a generic medication.[12][13] In the United Kingdom, it is available as a pharmacy medicine.[14]
Medical uses
Erectile dysfunction
The primary indication of sildenafil is treatment of erectile dysfunction (inability to sustain a satisfactory erection to complete sexual intercourse). Its use is now one of the standard treatments for erectile dysfunction, including for males with diabetes mellitus.[15]
Antidepressant-associated erectile dysfunction
Tentative evidence suggests that sildenafil may help males who experience antidepressant-induced erectile dysfunction.[16]
Antidepressant-associated erectile dysfunction
Tentative evidence suggests that sildenafil may help males who experience antidepressant-induced erectile dysfunction.[16]
Pulmonary hypertension
While sildenafil improves some markers of disease in people with pulmonary arterial hypertension, it does not appear to affect the risk of death or serious side effects.[17]
Raynaud's phenomenon
Sildenafil and other PDE5 inhibitors are used off-label to alleviate vasospasm and treat severe ischemia and ulcers in fingers and toes for people with secondary Raynaud's phenomenon; these drugs have moderate efficacy for reducing the frequency and duration of vasospastic episodes.[18] As of 2016, their role more generally in Raynaud's was not clear.[19]
Altitude sickness
Sildenafil has shown some potential for improving exercise performance at high altitudes. However, its overall efficacy is not clear.[20]
High-altitude pulmonary edema
Sildenafil has been studied for high-altitude pulmonary edema (HAPE), but its use is currently not recommended for that indication.[21]
High-altitude pulmonary edema
Sildenafil has been studied for high-altitude pulmonary edema (HAPE), but its use is currently not recommended for that indication.[21]
Adverse effects
In clinical trials, the most common adverse effects of sildenafil use included headache, flushing, indigestion, nasal congestion, and impaired vision, including photophobia and blurred vision. Some sildenafil users have complained of seeing everything tinted blue (cyanopsia).[22] This cyanopsia can be explained because sildenafil, while selective for PDE5, does have some affinity for PDE6, which is the phosphodiesterase found in the retina. Patients thus taking the drug may experience colorvision abnormalities. Some complained of blurriness and loss of peripheral vision. In July 2005, the US Food and Drug Administration (FDA) updated labeling for tadalafil (Cialis), vardenafil (Levitra), and sildenafil (Viagra) to reflect a small number of post-marketing reports of sudden vision loss, while acknowledging that "...it is not possible to determine whether these oral medicines for erectile dysfunction were the cause of the loss of eyesight or whether the problem is related to other factors such as high blood pressure or diabetes, or to a combination of these problems."[23] A careful review of pooled data from clinical trials containing well documented information about the dose and duration of exposure to the drug for a large number of patients, yields no evidence for an increased risk of non-arteritic anterior ischemic optic neuropathy or other adverse ocular events associated with PDE5 inhibitor use.[24]
Rare but serious adverse effects found through postmarketing surveillance include prolonged erections, severe low blood pressure, myocardial infarction (heart attack), ventricular arrhythmias, stroke, increased intraocular pressure, and sudden hearing loss. In October 2007, the FDA announced that the labeling for all PDE5 inhibitors, including sildenafil, required a more prominent warning of the potential risk of sudden hearing loss.[25]
Interactions
Care should be exercised by people who are also taking protease inhibitors for the treatment of HIV infection. Protease inhibitors inhibit the metabolism of sildenafil, effectively multiplying the plasma levels of sildenafil, increasing the incidence and severity of side effects. Those using protease inhibitors are recommended to limit their use of sildenafil to no more than one 25 mg dose every 48 hours. Other drugs that interfere with the metabolism of sildenafil include erythromycin and cimetidine, both of which can also lead to prolonged plasma half-life levels.[26]
The use of sildenafil and an α1 blocker (typically prescribed for hypertension or for urologic conditions, such as benign prostatic hypertrophy) at the same time may lead to low blood pressure, but this effect does not occur if they are taken at least 4 hours apart.[27]
Contraindications
Contraindications include:[28]
Sildenafil should not be used if sexual activity is inadvisable due to underlying cardiovascular risk factors.[30]
- Concomitant use of nitric oxide donors, organic nitrites and nitrates,[29] such as:
- nitroglycerin
- isosorbide mononitrate
- isosorbide dinitrate
- sodium nitroprusside
- alkyl nitrites (commonly known as "poppers")
- Concomitant use of soluble guanylyl cyclase stimulators, such as riociguat
- Known hypersensitivity to sildenafil
Non-medical use
Recreational use
Sildenafil's popularity with young adults has increased over the years.[31] Sildenafil's brand name, Viagra, is widely recognized in popular culture, and the drug's association with treating erectile dysfunction has led to its recreational use.[32] The reasons behind such use include the belief that the drug increases libido, improves sexual performance,[32] or permanently increases penis size.[33] Studies on the effects of sildenafil when used recreationally are limited, but suggest it has little effect when used by those who do not have erectile dysfunction. In one study, a 25 mg dose was shown to cause no significant change in erectile quality, but did reduce the postejaculatory refractory time.[34] This study also noted a significant placebo effect in the control group.[34]
Unprescribed recreational use of sildenafil and other PDE5 inhibitors is noted as particularly high among users of illegal drugs.[35] Sildenafil is sometimes used to counteract the effects of other substances, often illicit.[32] Some users mix it with methylenedioxymethamphetamine (MDMA, ecstasy), other stimulants, or opiates in an attempt to compensate for the common side effect of erectile dysfunction, a combination known as "sextasy", "rockin' and rollin'", "hammerheading", or "trail mix".[32] Mixing it with amyl nitrite, another vasodilator, is particularly dangerous and potentially fatal.[32]
Jet lag research
The 2007 Ig Nobel Prize in aviation went to Patricia V. Agostino, Santiago A. Plano, and Diego A. Golombek of Universidad Nacional de Quilmes, Argentina, for their discovery that sildenafil helps treat jet lag recovery in hamsters.[36][37]
Sports
Professional athletes have been documented using sildenafil, believing the opening of their blood vessels will enrich their muscles. In turn, they believe it will enhance their performances.[38][39]
Analogs
Acetildenafil and other synthetic structural analogs of sildenafil which are PDE5 inhibitors have been found as adulterants in a number of "herbal" aphrodisiac products sold over-the-counter.[40] These analogs have not undergone any of the rigorous testing that drugs like sildenafil have passed, and thus have unknown side-effect profiles.[41] Some attempts have been made to ban these drugs, but progress has been slow so far, as, even in those jurisdictions that have laws targeting designer drugs, the laws are drafted to ban analogs of illegal drugs of abuse, rather than analogs of prescription medicines. However, at least one court case has resulted in a product being taken off the market.[42]
The US Food and Drug Administration (FDA) has banned numerous products claiming to be Eurycoma longifolia that, in fact, contain only analogs of sildenafil.[43][44][45] Sellers of such fake herbals typically respond by just changing the names of their products.
Detection in biological fluids
Sildenafil and/or N-desmethylsildenafil, its major active metabolite, may be quantified in plasma, serum, or whole blood to assess pharmacokinetic status in those receiving the drug therapeutically, to confirm the diagnosis in potential poisoning victims, or to assist in the forensic investigation in a case of fatal overdose.[46]
Mechanism of action
Sildenafil protects cyclic guanosine monophosphate (cGMP) from degradation by cGMP-specific phosphodiesterase type 5 (PDE5) in the corpus cavernosum. Nitric oxide (NO) in the corpus cavernosum of the penis binds to guanylate cyclase receptors, which results in increased levels of cGMP, leading to smooth muscle relaxation (vasodilation) of the intimal cushions of the helicine arteries. This smooth muscle relaxation leads to vasodilation and increased inflow of blood into the spongy tissue of the penis, causing an erection.[48] Robert F. Furchgott, Ferid Murad, and Louis Ignarro won the Nobel Prize in Physiology or Medicine in 1998 for their independent study of the metabolic pathway of nitric oxide in smooth muscle vasodilation.
The molecular mechanism of smooth muscle relaxation involves the enzyme CGMP-dependent protein kinase, also known as PKG. This kinase is activated by cGMP and it phosphorylates multiple targets in the smooth muscle cells, namely myosin light chain phosphatase, RhoA, IP3 receptor, phospholipase C, and others.[49] Overall, this results in a decrease in intracellular calcium and desensitizing proteins to the effects of calcium, engendering smooth muscle relaxation.[49]
Sildenafil is a potent and selective inhibitor of cGMP-specific phosphodiesterase type 5 (PDE5), which is responsible for degradation of cGMP in the corpus cavernosum. The molecular structure of sildenafil is similar to that of cGMP and acts as a competitive binding agent of PDE5 in the corpus cavernosum, resulting in more cGMP and increased penile response to sexual stimulation.[48][50] Without sexual stimulation, and therefore lack of activation of the NO/cGMP system, sildenafil should not cause an erection. Other drugs that operate by the same mechanism include tadalafil (Cialis) and vardenafil (Levitra).
Sildenafil is broken down in the liver by hepatic metabolism using cytochrome p450 enzymes, mainly CYP450 3A4 (major route), but also by CYP2C9 (minor route) hepatic isoenzymes. The major product of metabolisation by these enzymes is N-desmethylated sildenafil, which is metabolised further. This metabolite also has an affinity for the PDE receptors, about 40% of that of sildenafil. Thus, the metabolite is responsible for about 20% of sildenafil's action. Sildenafil is excreted as metabolites predominantly in the feces (about 80% of administered oral dose) and to a lesser extent in the urine (around 13% of the administered oral dose). If taken with a high-fat meal, absorption is reduced; the time taken to reach the maximum plasma concentration increases by around one hour, and the maximum concentration itself is decreased by nearly one-third.[51]
Route of administration
- When taken orally, sildenafil for erectile dysfunction results in an average time to onset of erections of 27 minutes (ranging from 12 to 70 minutes).[52]
- Sublingual use of sildenafil for erectile dysfunction results in an average onset of action of 15 minutes and lasting for an average of 40 minutes.[53]
Chemical synthesis
The preparation steps for synthesis of sildenafil are:[54]
- 1) Methylation of 3-propylpyrazole-5-carboxylic acid ethyl ester with hot dimethyl sulfate
- 2) Hydrolysis with aqueous sodium hydroxide (NaOH) to free acid
- 3) Nitration with oleum/fuming nitric acid
- 4) Carboxamide formation with refluxing thionyl chloride/NH4OH
- 5) Reduction of nitro group to amino group
- 6) Acylation with 2-ethoxybenzoyl chloride
- 7) Cyclization
- 8) Sulfonation to the chlorosulfonyl derivative
- 9) Condensation with 1-methylpiperazine.
History
Sildenafil (compound UK-92,480) was synthesized by a group of pharmaceutical chemists led by Simon Campbell[55] working at Pfizer's Sandwich, Kent, research facility in England. It was initially studied for use in hypertension (high blood pressure) and angina pectoris (a symptom of ischaemic heart disease).[56] The first clinical trials were conducted in Morriston Hospital in Swansea.[57] Phase I clinical trials under the direction of Ian Osterloh suggested the drug had little effect on angina, but it could induce marked penile erections.[58][59] Pfizer therefore decided to market it for erectile dysfunction, rather than for angina; this decision became an often-cited example of drug repositioning.[60][61] The drug was patented in 1996, approved for use in erectile dysfunction by the FDA on 27 March 1998, becoming the first oral treatment approved to treat erectile dysfunction in the United States, and offered for sale in the United States later that year.[62] It soon became a great success: annual sales of Viagra peaked in 2008 at US$1.934 billion.[63]
Society and culture
Marketing and sales
In the US, even though sildenafil is available only by prescription from a doctor, it was advertised directly to consumers on TV (famously being endorsed by former United States Senator Bob Dole and football star Pelé). Numerous sites on the Internet offer Viagra for sale after an "online consultation", often a simple web questionnaire.[64][65]
Viagra and other products for sexual dysfunction, termed sexuopharmaceuticals, proliferated new types of specialised marketing for such products.[66] Viagra and similar prescription pharmaceuticals were promoted by images in media to the extent of becoming a cultural icon, at the time a relatively new phenomenon known to be permitted only in the United States and New Zealand and which is believed to have significantly contributed to norms regarding male sexuality.[67] One author notes that although the effect of Viagra is only limited to penile blood vessels, advertisements routinely use imagery of couples hugging, smiling and dancing, with the author claiming that pharmaceutical companies were deceptive in the use of such advertisements.[68]
In 2000, Viagra sales accounted for 92% of the global market for prescribed erectile dysfunction pills.[69] By 2007, Viagra's global share had plunged to about 50%[70] due to several factors, including the entry of Cialis and Levitra, along with several counterfeits and clones, and reports of vision loss in people taking PDE5 inhibitors.[71][72] In 2008, the FDA forced Pfizer to remove Viva Cruiser, an advergame for Viagra, from appearing on Forbes, after the game failed to disclose risk information about the drug.[73][74]
In February 2007, it was announced that Boots, the UK pharmacy chain, would try over-the-counter sales of Viagra in stores in Manchester, England. Males between the ages of 30 and 65 would be eligible to buy four tablets after a consultation with a pharmacist.[75] In 2017, the Medicines and Healthcare products Regulatory Agency (MHRA) enacted legislation that expanded this nationwide,[76] allowing a particular branded formulation of Sildenafil, Viagra Connect (50 mg), to be sold over the counter and without a prescription throughout the UK from early 2018. While the sale remains subject to a consultation with a pharmacist, the other restrictions from the trial have been removed, allowing customers over the age of 18 to purchase an unlimited number of pills.[77]
In May 2013, Pfizer, which manufactures Viagra, told the Associated Press they will begin selling the drug directly to people on its website.[78]
Pfizer's patents on Viagra expired outside the US in 2012; in the US they were set to expire, but Pfizer settled litigation with each of Mylan and Teva which agreed that both companies could introduce generics in the US in December 2017.[79][80] In December 2017, Pfizer released its own generic version of Viagra.[81][82]
As of 2018, the US Food and Drug Administration has approved fifteen drug manufacturers to market generic sildenafil in the United States. Seven of these companies are based in India.[83][84]
The patent for Pfizer's Viagra sildenafil to treat erectile dysfunction expired in April 2020.[85]
In 2026 a chocolate syrup called Boner Bears from Lockout Supplements was recalled through the FDA because of it containing Sildenafil as an undisclosed ingredient.[86][87]
Counterfeits
Counterfeit Viagra, despite generally being cheaper,[88] can contain harmful substances or substances that affect how Viagra works, such as blue printer ink, amphetamines, metronidazole, boric acid, and rat poison.[89]
Viagra is one of the world's most counterfeited medicines.[90][91] According to a 2012 Pfizer study, around 80% of sites claiming to sell Viagra were selling counterfeits.[89]
An October 2023 release stated that erectile dysfunction medicines were the most seized drugs by the Interpol[92] accounting for 22% of seizures.[93] International networks may be active.[94][95]
Regional issues
United States
In 1992, Pfizer filed a patent covering the substance sildenafil and its use to treat cardiovascular diseases.[96] This would be marketed as Revatio. The patent was published in 1993 and expired in 2012. The patent on Revatio (indicated for pulmonary arterial hypertension rather than erectile dysfunction) expired in late 2012. Generic versions of this low-dose form of sildenafil have been available in the US from a number of manufacturers, including Greenstone, Mylan, and Watson, since early 2013.[97] Health care providers may prescribe generic sildenafil for erectile dysfunction. For a time, the generic was not available in the same dosages as branded Viagra, so using dosages typically required for treating ED required patients to take multiple pills.
In 1994, Pfizer filed a patent covering the use of sildenafil to treat erectile dysfunction.[98] This would be marketed as Viagra. This patent was published in 2002 and expired in 2019. Teva sued to have the latter patent invalidated, but Pfizer prevailed in an August 2011 federal district court case.[99] An agreement with Pfizer allowed Teva to begin to provide the generic drug in December 2017.
In the United States, Pfizer received two patents for sildenafil: one for its indication to treat cardiovascular disease (marketed as Revatio) and another for its indication to treat erectile dysfunction (marketed as Viagra). The substance is the same under both brand names.
Sildenafil is available as a generic drug in the United States, labeled for pulmonary arterial hypertension,[100] and to treat erectile dysfunction, as the patent expired in April 2020.[85]
In the US, Revatio and Viagra are marketed by Viatris after Upjohn was spun off from Pfizer.[101][102][103][104]
Brazil
Pfizer's patent on sildenafil citrate expired in Brazil in 2010.[105]
Canada
In Canada, Pfizer's patent 2,324,324 for Revatio (sildenafil used to treat pulmonary hypertension) was found invalid by the Federal Court in June 2010, on an application by Ratiopharm Inc.[106][107]
On 8 November 2012, the Supreme Court of Canada ruled that Pfizer's patent 2,163,446 on Viagra was invalid from the beginning because the company did not provide full disclosure in its application. The decision, Teva Canada Ltd. v. Pfizer Canada Inc., pointed to section 27(3)(b) of The Patent Act which requires that disclosure must include sufficient information "to enable any person skilled in the art or science to which it pertains" to produce it. It added further: "As a matter of policy and sound statutory interpretation, patentees cannot be allowed to 'game' the system in this way. This, in my view, is the key issue in this appeal."[108]
Teva Canada launched Novo-Sildenafil, a generic version of Viagra, on the day the Supreme Court of Canada released its decision.[109][110][111] To remain competitive, Pfizer then reduced the price of Viagra in Canada.[112] However, on 9 November 2012, Pfizer filed a motion for a re-hearing of the appeal in the Supreme Court of Canada,[113] on the grounds that the court accidentally exceeded its jurisdiction by voiding the patent.[114] Finally, on 22 April 2013, the Supreme Court of Canada invalidated Pfizer's patent altogether.[115]
China
Manufacture and sale of sildenafil citrate drugs is common in China, where Pfizer's patent claim is not widely enforced.
Egypt
Egypt approved Viagra for sale in 2002, but soon afterwards allowed local companies to produce generic versions of the drug, citing the interests of poor people who would not be able to afford Pfizer's price.[116]
European Union
In June 2013 Pfizer's patent on sildenafil citrate expired in some member countries of the European Union, including Austria, Denmark, France, Germany, Ireland, Italy, The Netherlands, Spain, Sweden, the United Kingdom, and Switzerland.[117][118][119] A UK patent held by Pfizer on the use of PDE5 inhibitors (see below) as treatment of impotence was invalidated in 2000 because of obviousness; this decision was upheld on appeal in 2002.[120][121]
India
Manufacture and sale of sildenafil citrate drugs known as "generic Viagra" is common in India, where Pfizer's patent claim does not apply. Brand names include Kamagra (Ajanta Pharma), Silagra (Cipla), Edegra (Sun Pharmaceutical), Penegra (Zydus Cadila), Manly (Cooper Pharma) and Zenegra (Alkem Laboratories).
New Zealand
Sildenafil was reclassified in New Zealand in 2014 so it could be bought over the counter from a pharmacist. It is thought that this reduced sales over the Internet and was safer as males could be referred for medical advice if appropriate.[122]
South Korea
In 1999 South Korea granted two patents to Pfizer related to sildenafil. The first document guaranteed sole production and sale of the substance until 2012, while the second gave Pfizer the exclusive use to treating erectile dysfunction with sildenafil until 2014.[123] In 2011 Hanmi Pharmaceutical and CJ CheilJedang launched a suit against the exclusive use patent. The Korean Court system made a ruling against Pfizer in June 2012, allowing for the unhindered domestic production of generic prescription sildenafil.[124]
In 2012, Viagra lost its position as the top selling erectile dysfunction treatment in South Korea. This development was credited largely "due to the introduction of generic products." Generic sildenafil became publicly available in May. Sales of PalPal by Hanmi Pharmaceuticals totalled ₩22 billion or about 86% the market share of Viagra that year.[125] By 2017, there were over 50 generic sildenafil pills available. During that year Viagra sales slumped to 38% that of Palpal.[126]
United Kingdom
There were 2,958,199 prescriptions for Sildenafil in 2016 in England, compared with 1,042,431 in 2006.[127]
In 2018, Viagra Connect, a particular formulation of Sildenafil marketed by Pfizer, became available for sale without a prescription in the UK.[77][128][129][130]
United States
In 1992, Pfizer filed a patent covering the substance sildenafil and its use to treat cardiovascular diseases.[96] This would be marketed as Revatio. The patent was published in 1993 and expired in 2012. The patent on Revatio (indicated for pulmonary arterial hypertension rather than erectile dysfunction) expired in late 2012. Generic versions of this low-dose form of sildenafil have been available in the US from a number of manufacturers, including Greenstone, Mylan, and Watson, since early 2013.[97] Health care providers may prescribe generic sildenafil for erectile dysfunction. For a time, the generic was not available in the same dosages as branded Viagra, so using dosages typically required for treating ED required patients to take multiple pills.
In 1994, Pfizer filed a patent covering the use of sildenafil to treat erectile dysfunction.[98] This would be marketed as Viagra. This patent was published in 2002 and expired in 2019. Teva sued to have the latter patent invalidated, but Pfizer prevailed in an August 2011 federal district court case.[99] An agreement with Pfizer allowed Teva to begin to provide the generic drug in December 2017.
In the United States, Pfizer received two patents for sildenafil: one for its indication to treat cardiovascular disease (marketed as Revatio) and another for its indication to treat erectile dysfunction (marketed as Viagra). The substance is the same under both brand names.
Sildenafil is available as a generic drug in the United States, labeled for pulmonary arterial hypertension,[100] and to treat erectile dysfunction, as the patent expired in April 2020.[85]
In the US, Revatio and Viagra are marketed by Viatris after Upjohn was spun off from Pfizer.[101][102][103][104]
Brazil
Pfizer's patent on sildenafil citrate expired in Brazil in 2010.[105]
Canada
In Canada, Pfizer's patent 2,324,324 for Revatio (sildenafil used to treat pulmonary hypertension) was found invalid by the Federal Court in June 2010, on an application by Ratiopharm Inc.[106][107]
On 8 November 2012, the Supreme Court of Canada ruled that Pfizer's patent 2,163,446 on Viagra was invalid from the beginning because the company did not provide full disclosure in its application. The decision, Teva Canada Ltd. v. Pfizer Canada Inc., pointed to section 27(3)(b) of The Patent Act which requires that disclosure must include sufficient information "to enable any person skilled in the art or science to which it pertains" to produce it. It added further: "As a matter of policy and sound statutory interpretation, patentees cannot be allowed to 'game' the system in this way. This, in my view, is the key issue in this appeal."[108]
Teva Canada launched Novo-Sildenafil, a generic version of Viagra, on the day the Supreme Court of Canada released its decision.[109][110][111] To remain competitive, Pfizer then reduced the price of Viagra in Canada.[112] However, on 9 November 2012, Pfizer filed a motion for a re-hearing of the appeal in the Supreme Court of Canada,[113] on the grounds that the court accidentally exceeded its jurisdiction by voiding the patent.[114] Finally, on 22 April 2013, the Supreme Court of Canada invalidated Pfizer's patent altogether.[115]
China
Manufacture and sale of sildenafil citrate drugs is common in China, where Pfizer's patent claim is not widely enforced.
Egypt
Egypt approved Viagra for sale in 2002, but soon afterwards allowed local companies to produce generic versions of the drug, citing the interests of poor people who would not be able to afford Pfizer's price.[116]
European Union
In June 2013 Pfizer's patent on sildenafil citrate expired in some member countries of the European Union, including Austria, Denmark, France, Germany, Ireland, Italy, The Netherlands, Spain, Sweden, the United Kingdom, and Switzerland.[117][118][119] A UK patent held by Pfizer on the use of PDE5 inhibitors (see below) as treatment of impotence was invalidated in 2000 because of obviousness; this decision was upheld on appeal in 2002.[120][121]
India
Manufacture and sale of sildenafil citrate drugs known as "generic Viagra" is common in India, where Pfizer's patent claim does not apply. Brand names include Kamagra (Ajanta Pharma), Silagra (Cipla), Edegra (Sun Pharmaceutical), Penegra (Zydus Cadila), Manly (Cooper Pharma) and Zenegra (Alkem Laboratories).
New Zealand
Sildenafil was reclassified in New Zealand in 2014 so it could be bought over the counter from a pharmacist. It is thought that this reduced sales over the Internet and was safer as males could be referred for medical advice if appropriate.[122]
South Korea
In 1999 South Korea granted two patents to Pfizer related to sildenafil. The first document guaranteed sole production and sale of the substance until 2012, while the second gave Pfizer the exclusive use to treating erectile dysfunction with sildenafil until 2014.[123] In 2011 Hanmi Pharmaceutical and CJ CheilJedang launched a suit against the exclusive use patent. The Korean Court system made a ruling against Pfizer in June 2012, allowing for the unhindered domestic production of generic prescription sildenafil.[124]
In 2012, Viagra lost its position as the top selling erectile dysfunction treatment in South Korea. This development was credited largely "due to the introduction of generic products." Generic sildenafil became publicly available in May. Sales of PalPal by Hanmi Pharmaceuticals totalled ₩22 billion or about 86% the market share of Viagra that year.[125] By 2017, there were over 50 generic sildenafil pills available. During that year Viagra sales slumped to 38% that of Palpal.[126]
United Kingdom
There were 2,958,199 prescriptions for Sildenafil in 2016 in England, compared with 1,042,431 in 2006.[127]
In 2018, Viagra Connect, a particular formulation of Sildenafil marketed by Pfizer, became available for sale without a prescription in the UK.[77][128][129][130]
External links
References
- Sildenafil Use During Pregnancy Drugs.com, 7 October 2019, retrieved 6 October 2020^
- Viagra 25mg film-coated tablets Summary of Product Characteristics (SmPC) electronic medicines compendium (emc), 30 September 2024, retrieved 18 October 2025^
- Viagra Connect 50 mg film-coated tablets Summary of Product Characteristics (SmPC) electronic medicines compendium (emc), 16 May 2024, retrieved 18 October 2025^
- Viagra EPAR European Medicines Agency, 17 September 2018, retrieved 6 October 2020^
- Revatio EPAR European Medicines Agency, 17 September 2018, retrieved 6 October 2020^
- Pharmacokinetics of sildenafil after single oral doses in healthy male subjects: absolute bioavailability, food effects and dose proportionality British Journal of Clinical Pharmacology, 6 March 2002^
- Sildenafil Citrate The American Society of Health-System Pharmacists, retrieved 1 December 2014^
- The Serendipitous Story of Sildenafil: An Unexpected Oral Therapy for Erectile Dysfunction Sexual Medicine Reviews, January 2019^
- Drug Approval Package: Viagra (sildenafil citrate) NDA #020895 U.S. Food and Drug Administration (FDA), 27 March 1998, retrieved 15 February 2021^
- Top 300 of 2023 ClinCalc, retrieved 12 August 2025^
- Sildenafil Drug Usage Statistics, United States, 2013 - 2023 ClinCalc, retrieved 18 August 2025^
- Generic Viagra: Two versions of sildenafil hit the market today CBS News, 11 December 2017, retrieved 24 November 2018^
- Competitive Generic Therapy Approvals U.S. Food and Drug Administration (FDA), 3 March 2023, retrieved 6 March 2023^
- With Viagra Now Available Over-The-Counter In The U.K., Will The U.S. Follow Suit? Forbes, retrieved 24 November 2018^
- Phosphodiesterase inhibitors for erectile dysfunction in patients with diabetes mellitus The Cochrane Database of Systematic Reviews, January 2007^
- Strategies for managing sexual dysfunction induced by antidepressant medication The Cochrane Database of Systematic Reviews, May 2013, retrieved 30 November 2019^
- Efficacy and safety of sildenafil treatment in pulmonary arterial hypertension: a systematic review Respiratory Medicine, March 2014, retrieved 5 November 2016^
- Phosphodiesterase-5 inhibitors for the treatment of secondary Raynaud's phenomenon: systematic review and meta-analysis of randomised trials Annals of the Rheumatic Diseases, October 2013^
- Raynaud's phenomenon and digital ischaemia--pharmacologic approach and alternative treatment options VASA. Zeitschrift für Gefässkrankheiten, 2016^
- Efficacy of Sildenafil on healthy humans in high‑altitude hypoxia at rest and during exercise: A meta‑analysis Experimental and Therapeutic Medicine, February 2024^
- Interventions for preventing high altitude illness: Part 1. Commonly-used classes of drugs The Cochrane Database of Systematic Reviews, June 2017^
- Viagra and Vision VisionWeb, 29 October 2001, retrieved 5 November 2016^
- FDA Updates Labeling for Viagra, Cialis and Levitra for Rare Post-Marketing Reports of Eye Problems U.S. Food and Drug Administration (FDA), 8 July 2005, retrieved 5 November 2016^
- Vision disorders and phosphodiesterase type 5 inhibitors: a review of the evidence to date Drug Safety, January 2009^
- FDA Announces Revisions to Labels for Cialis, Levitra and Viagra U.S. Food and Drug Administration (FDA), 18 October 2007, retrieved 5 November 2016^
- Drug interactions with phosphodiesterase-5 inhibitors used for the treatment of erectile dysfunction or pulmonary hypertension Circulation, July 2010^
- Pharmacology and drug interaction effects of the phosphodiesterase 5 inhibitors: focus on alpha-blocker interactions The American Journal of Cardiology, December 2005^
- Viagra- sildenafil citrate tablet, film coated DailyMed, retrieved 6 October 2020^
- ACC/AHA expert consensus document. Use of sildenafil (Viagra) in patients with cardiovascular disease. American College of Cardiology/American Heart Association Journal of the American College of Cardiology, January 1999^
- Viagra (Sildenafil Citrate): Side Effects, Interactions, Warning, Dosage & Uses RxList, retrieved 11 July 2018^
- Young men add Viagra to their drug arsenal USA Today, 21 March 2001, retrieved 27 December 2013^
- Recreational use and misuse of phosphodiesterase 5 inhibitors Journal of the American Pharmacists Association, 2005^
- Sildenafil Will Not Affect Libido - Fact! retrieved 15 July 2016^
- Sildenafil does not improve sexual function in men without erectile dysfunction but does reduce the postorgasmic refractory time International Journal of Impotence Research, June 2003^
- - The rise of Viagra among British illicit drug users: 5-year survey data Drug and Alcohol Review, March 2006 Does marijuana use play a role in the recreational use of sildenafil? The Journal of Family Practice, November 2007^
- The 2007 Ig Nobel Prize Winners Improbable Research, 4 October 2007, retrieved 10 February 2009^
- Sildenafil accelerates reentrainment of circadian rhythms after advancing light schedules Proceedings of the National Academy of Sciences of the United States of America, June 2007^
- Source: Roger Clemens, host of athletes pop Viagra to help onfield performance Daily News, 10 June 2008, retrieved 10 February 2009^
- Bears' Brandon Marshall says some NFL players use Viagra ... on the Field Yahoo! Sports, 28 November 2012, retrieved 28 November 2012^
- Towards a decade of detecting new analogues of sildenafil, tadalafil and vardenafil in food supplements: a history, analytical aspects and health risks Journal of Pharmaceutical and Biomedical Analysis, October 2012^
- Detection of sildenafil analogues in herbal products for erectile dysfunction Journal of Toxicology and Environmental Health. Part A, November 2006^
- Designer drugs in herbal aphrodisiacs Forensic Science International, May 2008^
- FDA letter to Libidus distributor U.S. Food and Drug Administration (FDA), 11 July 2006^
- FDA Warns Consumers About Dangerous Ingredients in "Dietary Supplements" Promoted for Sexual Enhancement U.S. Food and Drug Administration (FDA), 12 July 2006^
- Hidden Risks of Erectile Dysfunction 'Treatments' Sold Online U.S. Food and Drug Administration (FDA), 21 February 2009, retrieved 8 December 2020^
- R. Baselt, Disposition of Toxic Drugs and Chemicals in Man, 9th edition, Biomedical Publications, Seal Beach, CA, 2011, pp. 1552–53. Sildenafil Biomedical Publications, retrieved 1 July 2011^
- Structure of the catalytic domain of human phosphodiesterase 5 with bound drug molecules Nature, September 2003^
- Sildenafil citrate and blood-pressure-lowering drugs: results of drug interaction studies with an organic nitrate and a calcium antagonist The American Journal of Cardiology, March 1999^
- cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action Pharmacological Reviews, September 2010^
- Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group The New England Journal of Medicine, May 1998^
- Viagra Clinical Pharmacology RxList.com, 2008, retrieved 20 August 2008^
- Onset and duration of action of sildenafil for the treatment of erectile dysfunction British Journal of Clinical Pharmacology, 2002^
- Sublingual sildenafil in the treatment of erectile dysfunction: faster onset of action with less dose International Journal of Urology, November 2004^
- Synthesis of Commercial Phosphodiesterase(V) Inhibitors Org Process Res Dev, 2005^
- Scientist who developed Viagra receives knighthood in New Year's Honours The Pharmaceutical Journal, Royal Pharmaceutical Society, 2014, retrieved 14 January 2023^
- Sildenafil: from angina to erectile dysfunction to pulmonary hypertension and beyond Nat Rev Drug Discov, August 2006^
- Research ABM, Abertawe Bro Morgannwg University Health Board, 4 July 2008, retrieved 6 August 2008^
- Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction International Journal of Impotence Research, June 1996^
- Sildenafil (Viagra), a potent and selective inhibitor of Type 5 cGMP phosphodiesterase with utility for the treatment of male erectile dysfunction Bioorg Med Chem Lett, 1996^
- Drug repositioning: identifying and developing new uses for existing drugs Nature Reviews. Drug Discovery, August 2004^
- Institute of Medicine. Drug Repurposing and Repositioning: Workshop Summary National Academies Press, 2014, retrieved 11 June 2017^
- From hypertension to angina to Viagra Mod. Drug Discov., 1998^
- Portions of the 2010 Financial Report retrieved 15 July 2016^
- Health situation in former communist bloc is dire, says Unicef BMJ, November 1999^
- Chemists plan to sell Viagra on the internet Daily Record, 29 September 2008, retrieved 30 April 2012^
- Sexual dysfunction or sexual discipline? Sexuopharmaceutical use by men as prevention and proficiency Feminism & Psychology, August 2018^
- Spreading the Word, but What Word is That? Viagra and Male Sexuality in Popular Culture Sexualities, July 2006^
- A new view of women's sexual problems: Why new? Why now? The Journal of Sex Research, 1 May 2001^
- The economics of Viagra Health Affairs, 2000^
- Cialis gaining market share worldwide Medical Marketing & Media, Haymarket Media, 1 January 2007, retrieved 10 February 2009^
- Viagra Chemical & Engineering News, 20 June 2005, retrieved 20 August 2008^
- Sales of Impotence Drugs Fall, Defying Expectations The New York Times, 4 December 2005, retrieved 20 August 2008^
- Pfizer Courting More Controversy with Viagra 'Advergaming' CBS News, 3 September 2008, retrieved 19 December 2019^
- FDA gave Pfizer hard time over Viagra game Engadget, 24 November 2008, retrieved 19 December 2019^
- Over-the-counter Viagra piloted BBC News, 11 February 2007, retrieved 10 February 2009^
- Viagra can be sold over the counter BBC News, 28 November 2017, retrieved 5 April 2018^
- Viagra now available over the counter without prescription in the UK The Independent, 27 March 2018, retrieved 5 April 2018^
- Pfizer to sell Viagra online, in first for Big Pharma: AP CBS News, retrieved 6 May 2013^
- The coming generics threat to Pfizer's Viagra brand just got scarier FiercePharma, 14 April 2015, retrieved 9 September 2017^
- Viagra to go generic in 2017 according to Pfizer agreement CBS News, 17 December 2013, retrieved 19 November 2017^
- Sex, Drugs and That Little Blue Pill Bloomberg, 6 December 2017, retrieved 10 December 2017^
- Why Pfizer Is About to Slash Viagra's Price in Half Fortune, 6 December 2017, retrieved 6 December 2017^
- Pfizer to lose patent of drug Viagra, Indian companies gear up with copycat versions: Pfizer's patent for the formulation of Viagra, used to treat impotence in men, ends in the US in 2020. Hindustan Times, 7 August 2018, retrieved 10 August 2018^
- Set to conquer US, Indian 'Viagras' may give Pfizer a hard Time The Economic Times, 3 August 2018, retrieved 10 August 2010^
- Pfizer Settles Viagra® Patent Litigation With Teva Pfizer, retrieved 17 March 2025^
- Chocolate syrup recalled over hidden Viagra Newsweek, 2026-02-26, retrieved 2026-02-26^
- Office of Inspections and Investigations. Lockout Supplements Issues Voluntary Nationwide Recall of Boner Bears Chocolate Syrup Due to Undeclared Sildenafil www.fda.gov, 2026-02-25, retrieved 2026-02-26^
- Record amount of counterfeit Viagra seized www.bbc.com, 12 May 2016, retrieved 26 December 2016^
- Counterfeit Viagra, Cialis, Levitra: The Ultimate Guide AccessRx, 22 May 2012, retrieved 10 January 2017^
- Cracking Down on Counterfeit Drugs PBS NOVA Next, 20 August 2013, retrieved 10 January 2017^
- Online pharmacies suspected of counterfeit drug sales CNN, 31 August 2015, retrieved 10 January 2017^
- Erectile Dysfunction Medication the Most Seized Drug During Global Crackdown, Interpol Says Forbes^
- Global illicit medicines targeted by INTERPOL operation retrieved 10 December 2023^
- Israeli-made AI exposes international fake Viagra network 19 April 2023, retrieved 10 December 2023^
- Counterfeit Viagra Pills, Footwear, Belts, Car Emblems and Headphones Worth over $32 Million Seized at the LA/Long Beach Seaport | U.S. Customs and Border Protection retrieved 10 December 2023^
- {{US patent|5250534}}^
- Pfizer's Revatio Goes Generic Zacks Equity Research, 15 November 2012, retrieved 5 October 2013^
- {{US patent|6469012}}^
- Pfizer Wins Viagra Patent Infringement Case Against Teva Pharmaceuticals Bloomberg, 15 August 2011, retrieved 1 April 2012^
- Yes, There Is a Way to Get Generic Viagra Consumer Reports, 4 March 2016, retrieved 4 May 2016^
- Pfizer Completes Transaction to Combine Its Upjohn Business with Mylan Pfizer, 16 November 2020, retrieved 17 June 2024^
- Revatio Pfizer, retrieved 17 June 2024^
- Viagra Pfizer, retrieved 17 June 2024^
- Brands Viatris, 16 November 2020, retrieved 17 June 2024^
- in-PharmaTechnologist.com. Viagra patent expires in June, says Brazilian court 28 April 2010, retrieved 15 July 2016^
- Revatio patent ruled invalid for lack of sound prediction and obviousness Canadian Technology & IP Law, Stikeman Elliott, 18 June 2010, retrieved 14 November 2012^
- Pfizer Canada Inc. v. Ratiopharm Inc., 2010 FC 612 CanLII, retrieved 27 December 2013^
- 8 November 2012^
- Supreme Court ruling could lead to cheaper versions of Viagra Toronto Star, 8 November 2012, retrieved 14 November 2012^
- Canadian Supreme court rules Viagra patent invalid Digital Journal, 8 November 2012, retrieved 14 November 2012^
- Viagra patent tossed out by Supreme Court: Decision allows generic versions of drug to be produced CBC News, 8 November 2012, retrieved 14 November 2012^
- Pfizer Canada drops Viagra price after generic versions get Supreme Court green light Financial Post, 22 November 2012, retrieved 9 February 2013^
- SCC Case Information, Docket No. 33951 January 2001, retrieved 14 November 2012^
- In rare move, Pfizer asks Supreme Court to reconsider ruling that killed Viagra patent The Globe and Mail, 15 November 2012, retrieved 15 November 2012^
- The Supreme Court of Canada holds Pfizer's Viagra patent invalid Lexology, 22 April 2013, retrieved 27 December 2013^
- Seeking Investment, Egypt Tries Patent Laws New York Times, 4 October 2002, retrieved 1 April 2013^
- Actavis Launches Generic Viagra in Europe as Patents Expire Yahoo Finance, 24 June 2013, retrieved 25 October 2013^
- What Will Happen When Viagra Goes Generic? AccessRx.com, 21 October 2009, retrieved 25 March 2011^
- Is Viagra about to lose its pulling power in the UK? The Guardian, 3 June 2013, retrieved 13 June 2013^
- Viagra ruling upsets Pfizer Telegraph Media Group Limited, 23 January 2002, retrieved 10 February 2009^
- Pfizer Loses UK Battle on Viagra Patent UroToday, Thomson Reuters, 17 June 2002, retrieved 10 February 2009^
- Viagra from the pharmacist: insight from reclassification in New Zealand Pharmaceutical Journal, 31 January 2018, retrieved 2 April 2018^
- Generic Viagra developers queue up, but may have to wait The Korea Herald, 14 March 2012, retrieved 28 December 2021^
- Approved Viagra copies flood drugstores in Korea Reuters, 1 June 2012, retrieved 28 December 2021^
- Viagra loses top spot in Korean market The Korea Herald, 10 April 2013, retrieved 28 December 2021^
- Hanmi leads erectile dysfunction drug sales KBR, 12 December 2017, retrieved 28 December 2021^
- Viagra prescriptions almost triple in a decade The Pharmaceutical Journal, 12 February 2021, retrieved 1 July 2024^
- MHRA reclassifies Viagra Connect tablets to a Pharmacy medicine^
- Viagra can be sold over the counter BBC News, 28 November 2017^
- Viagra to be available without prescription in UK CNN, 28 November 2017^